| [1] |
Nilsson OG,Lindgren A,Stahl N. et al. Incidence of intracerebral and subarachnoid hemorrhage in southern Sweden[J]. J Neurol Neurosurg Psychiatry, 2000, 69(5): 601-607
|
| [2] |
Nishijima DK,Shahlaie K,Sarkar K, et al. Risk of unfavorable long-term outcome in older adults with traumatic intracranial hemorrhage and anticoagulant or antiplatelet use[J]. Am J Emerg Med, 2013, 31(8): 1244-1247.
|
| [3] |
Hart RG,Pearce LA,Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation[J]. Ann Intern Med, 2007, 146(12): 857-867.
|
| [4] |
Apostolakis S,Sullivan RM,Olshansky B, et al. Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT2R2 score [J]. Chest, 2013, 144(5): 1555-1563
|
| [5] |
周良辅.重视颅脑创伤后凝血功能障碍的诊断和治疗[J].中华创伤杂志, 2015, 31(8): 673-675.
|
| [6] |
Franko J,Kish KJ,O'Connell BG, et al. Advanced age and preinjury warfarin anticoagulation increase the risk of mortality after head trauma[J]. J Trauma, 2006, 61(1): 107-110.
|
| [7] |
Allard CB,Scarpelini S,Rhind SG, et al. Abnormal coagulation tests are associated with progression of traumatic intracranial hemorrhage[J]. J Trauma, 2009, 67(5): 959-967.
|
| [8] |
Dzik WH. The James Blundell Award Lecture 2006: transfusion and the treatment of haemorrhage: past, present and future[J]. Transfus Med, 2007, 17(5): 367-374.
|
| [9] |
Karibe H,Hayashi T,Hirano T, et al. Surgical management of traumatic acute subdural hematoma in adults: a review[J]. Neurol Med Chir (Tokyo), 2014, 54(11): 887-894.
|
| [10] |
Lendrum RA,Kotze JP,Lockey DJ, et al. Case studies in prehospital care from London HEMS: pre-hospital administration of prothrombin complex concentrate to the head-injured patient[J]. Emerg Med J, 2013, 30(3): 247-248.
|
| [11] |
Raimondi P,Hylek EM,Aronis KN. Reversal agents for oral antiplatelet and anticoagulant treatment during bleeding events: current strategies[J]. Curr Pharm Des, 2017, 23(9): 1406-1423.
|
| [12] |
Siracuse JJ,Robich MP,Gautam S, et al. Antiplatelet agents, warfarin, and epidemic intracranial hemorrhage[J]. Surgery, 2010, 148(4): 724-729; discussion 729-730.
|
| [13] |
Grandhi R,Harrison G,Voronovich Z, et al. Preinjury warfarin, but not antiplatelet medications, increases mortality in elderly traumatic brain injury patients[J]. J Trauma Acute Care Surg, 2015, 78(3): 614-621.
|
| [14] |
Joseph B,Pandit V,Meyer D, et al. The significance of platelet count in traumatic brain injury patients on antiplatelet therapy[J]. J Trauma Acute Care Surg, 2014, 77(3): 417-421.
|
| [15] |
Washington CW,Schuerer DJ,Grubb RL Jr. Platelet transfusion: an unnecessary risk for mild traumatic brain injury patients on antiplatelet therapy[J]. J Trauma, 2011, 71(2): 358-363.
|
| [16] |
Joseph B,Aziz H,Pandit V, et al. Low-dose aspirin therapy is not a reason for repeating head computed tomographic scans in traumatic brain injury: a prospective study[J]. J Surg Res, 2014, 186(1): 287-291.
|
| [17] |
Davenport R. Pathogenesis of acute traumatic coagulopathy[J]. Transfusion, 2013, 53 Suppl 1: 23S-27S.
|
| [18] |
Fortuna GR,Mueller EW,James LE, et al. The impact of preinjury antiplatelet and anticoagulant pharmacotherapy on outcomes in elderly patients with hemorrhagic brain injury[J]. Surgery, 2008, 144(4): 598-603; discussion 603-605.
|
| [19] |
Olesen JB,Sorensen R,Hansen ML, et al. Non-vitamin K antagonist oral anticoagulation agents in anticoagulant na?ve atrial fibrillation patients: Danish nationwide descriptive data 2011-2013[J]. Europace, 2015, 17(2): 187-193.
|
| [20] |
Hylek EM,Held C,Alexander JH, et al. Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and Clinical Outcomes[J]. J Am Coll Cardiol, 2014, 63(20): 2141-2147.
|
| [21] |
Flaker GC,Eikelboom JW,Shestakovska O, et al. Bleeding during treatment with aspirin versus apixaban in patients with atrial fibrillation unsuitable for warfarin: the apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment (AVERROES) trial[J]. Stroke, 2012, 43(12): 3291-3297.
|
| [22] |
Abraham NS,Singh S,Alexander GC, et al. Comparative risK of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study[J]. BMJ, 2015, 350: h1857.
|
| [23] |
Pozzessere A,Grotts J,Kaminski S. Dabigatran use does not increase intracranial hemorrhage in traumatic geriatric falls when compared with warfarin[J]. Am Surg, 2015, 81(10): 1039-1042.
|
| [24] |
Goldhaber SZ,Polak JF,Feldstein ML, et al. Efficacy and safety of repeated boluses of urokinase in the treatment of deep venous thrombosis[J]. Am J Cardiol, 1994, 73(1): 75-79.
|
| [25] |
Medcalf RL. The traumatic side of fibrinolysis[J]. Blood, 2015, 125(16): 2457-2458.
|
| [26] |
Bolliger D,Zenklusen U,Tanaka KA. Point-of-care coagulation management algorithms during ECMO support: are we there yet?[J]. Minerva Anestesiol, 2016, 82(9): 1000-1009.
|
| [27] |
Scudday T,Brasel K,Webb T, et al. Safety and efficacy of prophylaCTic anticoagulation in patients with traumatic brain injury[J]. J Am Coll Surg, 2011, 213(1): 148-153; discussion 153-154.
|
| [28] |
Li S,Marks JA,Eisenstadt R, et al. Enoxaparin ameliorates post-traumatic brain injury edema and neurologic recovery, reducing cerebral leukocyte endothelial interactions and vessel permeability in vivo[J]. J Trauma Acute Care Surg, 2015, 79(1): 78-84.
|
| [29] |
Goldstein JN,Greenberg SM. Should anticoagulation be resumed after intracerebral hemorrhage?[J]. Cleve Clin J Med, 2010, 77(11): 791-799.
|
| [30] |
Hawryluk GW,Austin JW,Furlan JC, et al. Management of anticoagulation following central nervous system hemorrhage in patients with high thromboembolic risk[J]. J Thromb Haemost, 2010, 8(7): 1500-1508.
|
| [31] |
Yeon JY,Kong DS,Hong SC. Safety of early warfarin resumption following burr hole drainage for warfarin-associated subacute or chronic subdural hemorrhage[J]. J Neurotrauma, 2012, 29(7): 1334-1341.
|
| [32] |
Ruff CT,Giugliano RP,Braunwald E, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials[J]. Lancet, 2014, 383(9921): 955-962.
|
| [33] |
Shrestha S,Coy S,Bekelis K. Oral antiplatelet and anticoagulant agents in the prevention and management of ischemic stroke[J]. Curr Pharm Des, 2017, 23(9): 1377-1391.
|